POLICY DEBATES DURING THE PANDEMIC
Transforming the future of healthcare
Do cell and gene therapies hold the key?
While cell and gene therapies are constantly evolving and offer a lot of promise for rare and chronic conditions, they are also surrounded by a range of scientific, logistic and regulatory challenges. There is a clear need for decision-makers and experts to come together to define a sustainable way forward in ensuring safe and affordable access to novel treatments in this space. During this webinar our multi-stakeholder panel discussed transformative therapies and explored their impact on our health and on the systems that deliver them.
Watch the webinar
#TRANSFORMINGTOMORROW
Speakers
in the webinar
Bertalan Mesko
Director, The Medical Futurist Institute
Cristian Silviu Bușoi
MEP, European Parliament
Andrzej Rys
Director for Health Systems,DG SANTE, European Commission
Avril Daly
Vice-President, EURORDIS
Diane Kleinermans
President of the Commission of Drugs Reimbursement, Belgian National Institute for Health and Disability Insurance
Ilona G. Reischl
Quality Assessor - Biologics, Austrian Medicines and Medical Devices Agency (AGES/MEA)
Paige Bischoff
Senior Vice President, Global Public Affairs, Alliance for Regenerative Medicine (ARM)
Dan Hart
Honorary Consultant Haematologist, The Royal London Hospital Haemophilia Centre
Moderation: Vivienne Parry
Science journalist and writer, Head of Engagement, Genomics England